Search Results

Freedom Biosciences, Inc. (“Freedom Bio” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it may proceed with its FREE001-TRD-201 study for its lead program, FREE001, a ketamine-based combination therapy for the treatment of treatment-resistant depression (TRD).

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”) is pleased to announce data on the impact of the Freedom Infusion System on subcutaneous immunoglobulin (SCIg) therapy for primary immunodeficiency diseases (PIDD) to be presented at the National Home Infusion Association (NHIA) 2024 Conference.

PepGen Inc. (Nasdaq: PEPG) today announced that the first patient has been dosed in its Phase 1 clinical trial, FREEDOM-DM1, evaluating PGN-EDODM1 for the treatment of DM1.

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it received U.S. Food and Drug Administration (FDA) clearance for use of the FREEDOM60® Infusion System with Hizentra® 50 mL prefilled syringes (PFS).

KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60 ® Infusion System With Hizentra ® 50 Ml Prefilled Syringes.

A federal court sided in favor of Vanda Pharmaceuticals in its Freedom of Information Act case against the FDA regarding the CRL for its sleep drug label expansion.

Cook Medical, a global medical device manufacturer, has partnered with Bedal International, a company specializing in catheter securement devices marketed under the brand FlexGRIP®.

PepGen Inc. announced it has received a No Objection Letter from Health Canada for its Clinical Trial Application to initiate the FREEDOM-DM1 Phase 1 study of PGN-EDODM1 in patients with myotonic dystrophy type 1.

Thea Pharma Inc., the U.S. subsidiary of Europe’s leading independent ophthalmic-focused pharmaceutical company, Laboratoires Théa, announced the launch of the Preservative Freedom Coalition to raise awareness of unmet needs in ocular surface disease and opportunities to pursue preservative-free topical ophthalmic medications.